You are here

Sjögren’s syndrome

J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win

BioSpace

Mon, 06/17/24 - 11:36 am

clinical trials

Sjögren’s syndrome

J&J's immune disorder drug succeeds in mid and late-stage studies

Reuters

Mon, 02/5/24 - 10:14 am

autoimmune disease

clinical trials

myasthenia gravis

Sjögren’s syndrome

Amgen reports data from Sjögren’s Syndrome treatment trial

Clinical Trials Arena

Wed, 11/8/23 - 10:18 am

clinical trials

Sjögren’s syndrome

Horizon Bags Second Phase II Win in Sjögren’s Syndrome

BioSpace

Wed, 01/18/23 - 10:51 pm

Horizon Therapeutics

Sjögren’s syndrome

clinical trials

Horizon still has a mountain to climb

EP Vantage

Tue, 09/13/22 - 10:39 am

Horizon Therapeutics

Sjögren’s syndrome

Gilead’s filgotinib fails midphase tests in lupus, Sjogren's

Fierce Biotech

Fri, 10/25/19 - 10:39 am

Gilead Sciences

Sjögren’s syndrome

clinical trials

Upcoming events – Crucial data on zanubrutinib and filgotinib approach

EP Vantage

Fri, 06/14/19 - 10:14 am

Waldenström’s macroglobulinemia

Sjögren’s syndrome